GLOBOCAN 2022: Bladder cancer 9th most common worldwide

The International Agency for Research on Cancer (IARC) has recently published the updated GLOBOCAN 2022 with new estimates on the global cancer burden, indicating that it has risen to 19.9 million cases and 9.7 million cancer deaths in 2022.

The International Agency for Research on Cancer estimates that globally, 1 in 5 people develop cancer during their lifetime, and 1 in 9 men and 1 in 12 women die from the disease. These new estimates suggest that more than 53 million people are living within five years of a past cancer diagnosis. The aging global population and socio-economic factors are significant contributors to this increase.

Latest Bladder Cancer Statistics

Bladder cancer has moved up from the 10th to the 9th most commonly diagnosed cancer worldwide, with both incidence and mortality rates increasing. The new data estimated that 614,298 people were diagnosed with bladder cancer in 2022 around the world, marking a 7.1% increase from the data reported in 2020. The new 5-year prevalence estimates also show that 1,950,315 people (all genders) are living with bladder cancer within five years of a past diagnosis.

Focusing on gender-specific data, it estimates 523,674 new bladder cancer cases in men, representing 5.4% of all new cancer cases in men globally, making it the 6th most common cancer among men.

The GLOBOCAN 2022 database, a part of the broader IARC Global Cancer Observatory, serves as a crucial tool for researchers and policymakers, offering detailed cancer incidence and mortality estimates across 185 countries for 36 types of cancer and all cancer sites combined.

We invite you to visit our website and learn more about bladder cancer.

For the most current data and insights, visit the GLOBOCAN database.